A cross-talk between gut microbiome, salt and hypertension

• Main Authors: Salma Naqvi, Turky Omar Asar, Vikas Kumar, Fahad A. Al-Abbasi, Sultan Alhayyani, Mohammad Amjad Kamal, Firoz Anwar
• Format: Article
• Language: English
• Published: Elsevier 2021-02-01
• Series: Biomedicine & Pharmacotherapy
• Subjects: Gut microbiota; Hypertension; Salt; TMAO; Cardiovascular disease
• Online Access: http://www.sciencedirect.com/science/article/pii/S0753332220313494

Cardiac disorders contribute to one of the major causes of fatality across the world. Hypertensive patients, even well maintained on drugs, possess a high risk to cardiovascular diseases. It is, therefore, highly important to identify different factors and pathways that lead to risk and progression of cardiovascular disorders. Several animals and human studies suggest that taxonomical alterations in the gut are involved in the cardiovascular physiology. In this article, with the help of various experimental evidences, we suggest that the host gut-microbiota plays an important in this pathway. Short chain fatty acids (SCFAs) and Trimethyl Amine -n-Oxide (TMAO) are the two major products of gut microbiome. SCFAs present a crucial role in regulating the blood pressure, while TMAO is involved in pathogenesis of atherosclerosis and other coronary artery diseases, including hypertension. We prove that there exists a triangular bridge connecting the gap between dietary salt, hypertension and gut microbiome. We also present some of the dietary interventions which can regulate and control microbiota that can prevent cardiovascular complications.We strongly believe that this article would improve the understanding the role of gut microbiota in hypertension, and will be helpful in the development of novel therapeutic strategies for prevention of hypertension through restoring gut microbiome homeostasis in the near future